A NEW partnership between the trust and Synexus – a leading research company – has taken an exciting step forward with the opening of a new centre for clinical trials at the University Hospital of North Tees.
The aim is to increase the number of potentially complex studies available to patients from jointly running studies between the NHS and Synexus.
It will also bring more studies and greater opportunities to patients in the area.
Professor Samir Gupta, clinical director for research and development at North Tees and Hartlepool NHS Foundation Trust, said: “This new partnership will bring a wider variety of trials to the area, give more people the chance to take part and build on the fantastic progress the trust has made in research participation in the last few years. This is essential to being able to give the best care to our patients and access new treatments.
“Synexus is the world’s leading investigative site network for clinical trials. This is only the second time they have gone into partnership with an NHS trust, after they opened a centre at Hexham in Northumberland which has been a huge success. They may contact people directly to participate or may work with the trust to jointly run studies.
“We support and encourage research in this trust – it is very important to getting a greater medical understanding and develop more effective treatments. I am very excited to be working with Synexus to help move this further forward.”
Christophe Berthoux, chief executive at Synexus, said: “Each Synexus site is strategically placed to add value to the customers and patients we serve. Here in Stockton we look forward to conducting crucial research into a wide variety of therapy areas.
“With this in mind, Teesside is proving a valuable region for patient recruitment and their ongoing care and our commitment to finding solutions for the varied conditions we investigate will define everything we do at this leading facility.
“A new site like this is not achievable without the hard work and commitment of many people and I would like to thank all who have made this latest addition to the Synexus family possible.
“I would like to wish the growing North East team well. At our well-established Hexham site we have shown that Synexus is at the heart of a community, with several long term partnerships in place, meaning we are genuinely blazing a trail for high calibre, value added clinical research. I am confident this success will be mirrored here on Teesside.”
The trust used its annual research and development conference to launch the new service. The event featured presentations from speakers including Dr Jonathan Sheffield, director of the National Institute for Health Research (NIHR), professor Jenny Kurinczuk from the National Perinatal Epidemiology Unit at Oxford University and professor Steve Robson, clinical director at the NIHR Clinical Research Network North East and North Cumbria. Trust medical director Deepak Dwarakanath and research and development manage r Jane Greenaway spoke at the event.